Aprea Therapeutics, Inc.

Zentalis Validates a Multibillion-Dollar Cancer Market as Aprea Therapeutics Emerges as a Next-Generation Contender
Barchart.com · 22 Oct 2026
Aprea at Pre-ESMO Virtual Panel Conference: wEE1 bet leans on safety
Investing.com · 20 Oct 2026
Aprea Therapeutics Q3 2026 Earnings Date and Estimates
MarketBeat · 18 Oct 2026
APRE: Aprea Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas
Stocktwits · 07 Oct 2026
Aprea Therapeutics to Present at October Conferences
The Manila Times · 05 Oct 2026
Aprea to Present Updated APR-1051 Cancer Trial Data
MyChesCo · 25 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.